Adiponectin and future coronary heart disease events among men with type 2 diabetes.

PubWeight™: 1.87‹?› | Rank: Top 3%

🔗 View Article (PMID 15677512)

Published in Diabetes on February 01, 2005

Authors

Matthias B Schulze1, Iris Shai, Eric B Rimm, Tricia Li, Nader Rifai, Frank B Hu

Author Affiliations

1: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA. mschulze@mail.dife.de

Associated clinical trials:

Health Professionals Follow-up Study | NCT00005182

Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women | NCT00037258

Articles citing this

Cardiac remodeling in obesity. Physiol Rev (2008) 2.95

Adiponectin as an anti-inflammatory factor. Clin Chim Acta (2007) 2.56

Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr (2009) 2.22

Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One (2008) 2.02

Adiponectin actions in the cardiovascular system. Cardiovasc Res (2006) 1.92

The role of adiponectin in cancer: a review of current evidence. Endocr Rev (2012) 1.78

Lipotoxicity in the heart. Biochim Biophys Acta (2009) 1.60

Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab (2013) 1.58

Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol (2009) 1.58

Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol (2008) 1.53

APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab (2008) 1.41

Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study. Am J Clin Nutr (2008) 1.27

Inflammatory concepts of obesity. Int J Inflam (2011) 1.14

Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis (2011) 1.11

Cell communications in the heart. Circulation (2010) 1.09

Adiponectin and all-cause mortality in elderly people with type 2 diabetes. Diabetes Care (2012) 1.07

Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes. Diabetes (2010) 1.06

Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the jackson heart study. Front Public Health (2013) 1.02

Relatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: relation to sex hormone-binding globulin. Int J Biol Sci (2008) 1.02

Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. Curr Pharm Des (2013) 0.99

Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One (2012) 0.98

Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant (2008) 0.97

Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol (2009) 0.97

Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther (2010) 0.97

Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med (2011) 0.95

Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm (2012) 0.95

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovasc Diabetol (2011) 0.95

Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats. PLoS One (2012) 0.93

Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev (2013) 0.92

Obesity, inflammation, and lung injury (OILI): the good. Mediators Inflamm (2014) 0.91

Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res (2016) 0.91

Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance. Clin Exp Pharmacol Physiol (2011) 0.89

Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res (2012) 0.88

Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals. J Clin Endocrinol Metab (2015) 0.87

Niacin in cardiovascular disease: recent preclinical and clinical developments. Arterioscler Thromb Vasc Biol (2011) 0.87

Effects of sleep restriction on adiponectin levels in healthy men and women. Physiol Behav (2010) 0.86

The burden of type 2 diabetes: strategies to prevent or delay onset. Vasc Health Risk Manag (2007) 0.86

Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes. J Diabetes Investig (2013) 0.85

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med (2012) 0.85

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study. Cardiovasc Diabetol (2010) 0.84

Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients. Am J Kidney Dis (2015) 0.83

Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring) (2013) 0.83

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. AIDS (2014) 0.82

EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One (2011) 0.82

Impact of uremia on human adipose tissue phenotype. J Surg Res (2012) 0.82

Effects of Tai Chi on adiponectin and glucose homeostasis in individuals with cardiovascular risk factors. Eur J Appl Physiol (2010) 0.82

Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants. Eur J Epidemiol (2014) 0.81

Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo) (2011) 0.81

Effect of weight loss on adipokine levels in obese patients. Diabetes Metab Syndr Obes (2011) 0.81

Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. J Clin Endocrinol Metab (2011) 0.80

Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load. Exp Diabetes Res (2011) 0.80

Effects of niacin on atherosclerosis and vascular function. Curr Opin Cardiol (2011) 0.80

Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol (2012) 0.80

Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes. J Diabetes Res (2015) 0.79

Additional effect of diabetes mellitus type 2 on the risk of coronary artery disease: role of serum adiponectin. Iran Red Crescent Med J (2014) 0.79

Association between adiponectin concentrations and cardiovascular disease in diabetic patients: a systematic review and meta-analysis. PLoS One (2013) 0.79

Different impacts of metabolic syndrome components on insulin resistance in type 2 diabetes. Int J Endocrinol (2013) 0.78

Heart failure among South Asians: a narrative review of risk, nature, outcomes and management. Heart Fail Rev (2013) 0.78

Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes. J Diabetes Investig (2013) 0.78

The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients. Exp Clin Cardiol (2012) 0.77

Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population. Hepat Mon (2016) 0.77

Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome. Iran Red Crescent Med J (2014) 0.77

Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan. Cardiorenal Med (2013) 0.77

Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years. J Res Med Sci (2016) 0.75

Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes. J Am Heart Assoc (2016) 0.75

Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. J Diabetes Complications (2016) 0.75

Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study. Endocrine (2017) 0.75

Articles by these authors

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

A common genetic variant is associated with adult and childhood obesity. Science (2006) 14.95

Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr (2006) 13.19

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA (2009) 11.52

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68

C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47

A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 8.03

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA (2006) 7.73

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) (2008) 7.40

A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet (2013) 7.34

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Correlates of long sleep duration. Sleep (2006) 5.67

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med (2005) 5.27

Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation (2008) 5.26

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24

Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA (2012) 5.17

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med (2008) 4.98

C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94

Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92

Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr (2010) 4.85

Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol (2010) 4.83

Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA (2011) 4.75

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes (2004) 4.67

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care (2007) 4.63

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med (2011) 4.61

Association between reduced sleep and weight gain in women. Am J Epidemiol (2006) 4.59

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58

A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57

Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. JAMA (2011) 4.54

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Physical activity at midlife in relation to successful survival in women at age 70 years or older. Arch Intern Med (2010) 4.45

Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med (2003) 4.40

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24

Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19